DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

73.78 0.48 (0.65%)

REAL-TIME: Last trade at

Extended Hours: $72.44 -$1.34 (-1.82%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

AZN $73.78 0.65%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.78
Previous Close $73.30
Daily Range $73.44 - $73.96
52-Week Range $49.63 - $82.68
Market Cap $93.2B
P/E Ratio 35.93
Dividend (Yield) $1.80 (3.8%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/15/14
Volume 745,446
Average Daily Volume 2,471,648
Current FY EPS $4.46

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

Drugs Stocks On The Rise With Help From 3 Stocks

Teva Pharmaceutical Is Poised To Grow

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

A Top Dividend Stock for Your Portfolio: Johnson & Johnson

This healthcare stock offers investors an attractive dividend yield, a strong balance sheet, and a long history of market-beating returns.

AstraZeneca Presents Unfavorable Benralizumab Study Data - Analyst Blog

Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog

Why Illumina (ILMN) Stock Is Gaining Today

Pfizer: You Won't Fool Me Twice

See More AZN News...

AZN's Top Competitors

AZN $73.78 (0.65%)
Current stock: AZN
JNJ $104.72 (0.13%)
Current stock: JNJ
NVS $94.18 (0.45%)
Current stock: NVS
RHHBY $36.96 (0.71%)
Current stock: RHHBY